Provention Bio Inc buy Chardan Capital
Start price
13.03.23
/
50%
€22.41
Target price
13.03.24
€23.30
Performance (%)
1.07%
End price
14.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Chardan_Capital shows slight gains of 1.07%. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Provention Bio Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by Chardan_Capital for this prediction
In the thread Provention Bio Inc diskutieren
Provention Bio, Inc. (NASDAQ: PRVB) had its price target lowered by analysts at Chardan Capital from $30.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PRVB provided by MarketBeat
In the thread Trading Provention Bio Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten